| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.713 | 0.006 | 0.735 | 5 Hydroxytryptamine release stimulant | 0.708 0.006 DBMET00318 0.735 0.005 DBMET01700 0.735 0.005 DBMET01701 | DBMET01701 | |
| 0.609 | 0.025 | 0.609 | Analgesic | 0.417 0.077 DBMET00318 0.519 0.044 DBMET01700 0.519 0.044 DBMET01701 | ||
| 0.556 | 0.003 | 0.556 | Adrenaline uptake inhibitor | 0.323 0.004 DBMET00318 0.403 0.004 DBMET01700 0.403 0.004 DBMET01701 | ||
| 0.518 | 0.004 | 0.518 | 5 Hydroxytryptamine uptake inhibitor | 0.267 0.007 DBMET00318 0.35 0.005 DBMET01700 0.35 0.005 DBMET01701 | ||
| 0.532 | 0.019 | 0.585 | Spasmolytic | 0.413 0.038 DBMET00318 0.585 0.014 DBMET01700 0.585 0.014 DBMET01701 | DBMET01701 | |
| 0.526 | 0.019 | 0.532 | Calcium channel L-type activator | 0.532 0.017 DBMET01700 0.532 0.017 DBMET01701 | DBMET01701 | |
| 0.473 | 0.004 | 0.473 | Alpha 2b adrenoreceptor antagonist | 0.285 0.01 DBMET00318 0.43 0.005 DBMET01700 0.43 0.005 DBMET01701 | ||
| 0.464 | 0.003 | 0.464 | Dopamine uptake inhibitor | 0.277 0.004 DBMET00318 0.34 0.004 DBMET01700 0.34 0.004 DBMET01701 | ||
| 0.463 | 0.014 | 0.463 | Psychostimulant | 0.373 0.027 DBMET00318 0.436 0.017 DBMET01700 0.436 0.017 DBMET01701 | ||
| 0.438 | 0.016 | 0.438 | Sigma receptor agonist | 0.363 0.028 DBMET00318 0.424 0.018 DBMET01700 0.424 0.018 DBMET01701 | ||
| 0.401 | 0.009 | 0.416 | Lipocortins synthesis antagonist | 0.416 0.007 DBMET00318 0.376 0.011 DBMET01700 0.376 0.011 DBMET01701 | DBMET00318 | |
| 0.392 | 0.009 | 0.392 | 5 Hydroxytryptamine 2B antagonist | 0.309 0.014 DBMET00318 0.28 0.016 DBMET01700 0.28 0.016 DBMET01701 | ||
| 0.373 | 0.005 | 0.373 | Alpha 2c adrenoreceptor antagonist | 0.233 0.012 DBMET00318 0.344 0.005 DBMET01700 0.344 0.005 DBMET01701 | ||
| 0.384 | 0.022 | 0.4 | Sodium/bile acid cotransporter inhibitor | 0.377 0.025 DBMET00318 0.4 0.017 DBMET01700 0.4 0.017 DBMET01701 | DBMET01701 | |
| 0.368 | 0.009 | 0.368 | Cholinergic antagonist | 0.309 0.014 DBMET00318 0.332 0.012 DBMET01700 0.332 0.012 DBMET01701 | ||
| 0.387 | 0.03 | 0.387 | Calcium channel activator | 0.339 0.057 DBMET00318 0.365 0.04 DBMET01700 0.365 0.04 DBMET01701 | ||
| 0.428 | 0.077 | 0.428 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.337 0.165 DBMET00318 0.281 0.24 DBMET01700 0.281 0.24 DBMET01701 | ||
| 0.363 | 0.012 | 0.363 | 5 Hydroxytryptamine 2 antagonist | 0.214 0.027 DBMET00318 0.24 0.023 DBMET01700 0.24 0.023 DBMET01701 | ||
| 0.357 | 0.008 | 0.357 | Butyrylcholinesterase inhibitor | 0.307 0.01 DBMET00318 0.287 0.011 DBMET01700 0.287 0.011 DBMET01701 | ||
| 0.429 | 0.094 | 0.515 | Caspase 9 stimulant | 0.472 0.072 DBMET00318 0.515 0.054 DBMET01700 0.515 0.054 DBMET01701 | DBMET01701 | |
| 0.344 | 0.01 | 0.344 | Acetylcholine antagonist | 0.29 0.015 DBMET00318 0.307 0.013 DBMET01700 0.307 0.013 DBMET01701 | ||
| 0.327 | 0.01 | 0.327 | Acetylcholine M1 receptor antagonist | 0.326 0.01 DBMET00318 0.311 0.013 DBMET01700 0.311 0.013 DBMET01701 | ||
| 0.303 | 0.005 | 0.303 | Sigma receptor antagonist | 0.283 0.006 DBMET00318 0.183 0.009 DBMET01700 0.183 0.009 DBMET01701 | ||
| 0.294 | 0.009 | 0.294 | Acetylcholine muscarinic antagonist | 0.256 0.014 DBMET00318 0.271 0.012 DBMET01700 0.271 0.012 DBMET01701 | ||
| 0.275 | 0.004 | 0.275 | Histamine H2 receptor antagonist | 0.157 0.009 DBMET00318 0.172 0.007 DBMET01700 0.172 0.007 DBMET01701 | ||
| 0.302 | 0.032 | 0.302 | Gastrin inhibitor | 0.253 0.076 DBMET00318 0.24 0.092 DBMET01700 0.24 0.092 DBMET01701 | ||
| 0.285 | 0.017 | 0.285 | Nav1.2 sodium channel blocker | 0.258 0.02 DBMET00318 0.214 0.03 DBMET01700 0.214 0.03 DBMET01701 | ||
| 0.274 | 0.01 | 0.274 | Alpha 2 adrenoreceptor antagonist | 0.169 0.023 DBMET00318 0.247 0.012 DBMET01700 0.247 0.012 DBMET01701 | ||
| 0.282 | 0.033 | 0.282 | P-glycoprotein inhibitor | 0.236 0.046 DBMET00318 0.274 0.035 DBMET01700 0.274 0.035 DBMET01701 | ||
| 0.258 | 0.01 | 0.258 | Alpha 1b adrenoreceptor antagonist | 0.14 0.024 DBMET00318 0.221 0.013 DBMET01700 0.221 0.013 DBMET01701 | ||
| 0.251 | 0.009 | 0.251 | Alpha 2a adrenoreceptor antagonist | 0.161 0.02 DBMET00318 0.248 0.009 DBMET01700 0.248 0.009 DBMET01701 | ||
| 0.26 | 0.023 | 0.26 | 5 Hydroxytryptamine antagonist | 0.157 0.047 DBMET00318 0.145 0.052 DBMET01700 0.145 0.052 DBMET01701 | ||
| 0.232 | 0.004 | 0.232 | Acetylcholine M5 receptor antagonist | 0.161 0.006 DBMET00318 0.187 0.005 DBMET01700 0.187 0.005 DBMET01701 | ||
| 0.233 | 0.008 | 0.233 | Alpha 1d adrenoreceptor antagonist | 0.123 0.019 DBMET00318 0.183 0.011 DBMET01700 0.183 0.011 DBMET01701 | ||
| 0.235 | 0.013 | 0.235 | Nav1.1 sodium channel blocker | 0.188 0.021 DBMET00318 0.208 0.017 DBMET01700 0.208 0.017 DBMET01701 | ||
| 0.229 | 0.009 | 0.385 | Dopamine D1 antagonist | 0.149 0.015 DBMET00318 0.385 0.004 DBMET01700 0.385 0.004 DBMET01701 | DBMET01701 | |
| 0.303 | 0.085 | 0.304 | Vasodilator, coronary | 0.253 0.131 DBMET00318 0.304 0.084 DBMET01700 0.304 0.084 DBMET01701 | DBMET01701 | |
| 0.274 | 0.06 | 0.363 | 5 Hydroxytryptamine uptake stimulant | 0.363 0.022 DBMET00318 0.269 0.064 DBMET01700 0.269 0.064 DBMET01701 | DBMET00318 | |
| 0.214 | 0.009 | 0.242 | Opioid kappa receptor antagonist | 0.22 0.009 DBMET00318 0.242 0.007 DBMET01700 0.242 0.007 DBMET01701 | DBMET01701 | |
| 0.223 | 0.024 | 0.223 | Alpha adrenoreceptor antagonist | 0.108 0.052 DBMET00318 0.19 0.029 DBMET01700 0.19 0.029 DBMET01701 | ||
| 0.249 | 0.051 | 0.262 | Peptidyltransferase inhibitor | 0.262 0.043 DBMET00318 0.257 0.046 DBMET01700 0.257 0.046 DBMET01701 | DBMET00318 | |
| 0.218 | 0.021 | 0.218 | Antiadrenergic | 0.142 0.038 DBMET00318 0.183 0.028 DBMET01700 0.183 0.028 DBMET01701 | ||
| 0.201 | 0.004 | 0.201 | Dopamine transporter inhibitor | 0.16 0.005 DBMET00318 0.148 0.006 DBMET01700 0.148 0.006 DBMET01701 | ||
| 0.207 | 0.011 | 0.231 | Adenylate cyclase stimulant | 0.203 0.012 DBMET00318 0.231 0.005 DBMET01700 0.231 0.005 DBMET01701 | DBMET01701 | |
| 0.259 | 0.065 | 0.259 | 5 Hydroxytryptamine 1E antagonist | 0.194 0.138 DBMET00318 0.258 0.066 DBMET01700 0.258 0.066 DBMET01701 | ||
| 0.224 | 0.032 | 0.224 | 5 Hydroxytryptamine 3E antagonist | 0.209 0.049 DBMET00318 0.181 0.102 DBMET01700 0.181 0.102 DBMET01701 | ||
| 0.198 | 0.006 | 0.198 | Acetylcholine M4 receptor antagonist | 0.154 0.01 DBMET00318 0.108 0.023 DBMET01700 0.108 0.023 DBMET01701 | ||
| 0.21 | 0.019 | 0.21 | Antihistaminic | 0.114 0.046 DBMET00318 0.095 0.059 DBMET01700 0.095 0.059 DBMET01701 | ||
| 0.205 | 0.014 | 0.205 | Histamine H1 receptor antagonist | 0.139 0.027 DBMET00318 0.113 0.035 DBMET01700 0.113 0.035 DBMET01701 | ||
| 0.201 | 0.012 | 0.201 | 5 Hydroxytryptamine 7 antagonist | 0.198 0.013 DBMET00318 0.102 0.025 DBMET01700 0.102 0.025 DBMET01701 | ||
| 0.289 | 0.101 | 0.422 | Transcription factor NF kappa B inhibitor | 0.294 0.098 DBMET00318 0.422 0.059 DBMET01700 0.422 0.059 DBMET01701 | DBMET01701 | |
| 0.204 | 0.017 | 0.204 | 5 Hydroxytryptamine 2C antagonist | 0.137 0.03 DBMET00318 0.133 0.031 DBMET01700 0.133 0.031 DBMET01701 | ||
| 0.207 | 0.022 | 0.207 | Adrenaline antagonist | 0.131 0.04 DBMET00318 0.173 0.029 DBMET01700 0.173 0.029 DBMET01701 | ||
| 0.203 | 0.019 | 0.203 | Histamine antagonist | 0.105 0.045 DBMET00318 0.083 0.061 DBMET01700 0.083 0.061 DBMET01701 | ||
| 0.193 | 0.014 | 0.341 | Estrogen antagonist | 0.198 0.013 DBMET00318 0.341 0.005 DBMET01700 0.341 0.005 DBMET01701 | DBMET01701 | |
| 0.19 | 0.017 | 0.19 | Alpha 1a adrenoreceptor antagonist | 0.085 0.042 DBMET00318 0.144 0.024 DBMET01700 0.144 0.024 DBMET01701 | ||
| 0.252 | 0.081 | 0.252 | Cardiotonic | 0.201 0.118 DBMET00318 0.2 0.119 DBMET01700 0.2 0.119 DBMET01701 | ||
| 0.249 | 0.083 | 0.524 | Aldehyde oxidase inhibitor | 0.349 0.055 DBMET00318 0.524 0.029 DBMET01700 0.524 0.029 DBMET01701 | DBMET01701 | |
| 0.186 | 0.021 | 0.186 | 5 Hydroxytryptamine 2A antagonist | 0.107 0.043 DBMET00318 0.114 0.04 DBMET01700 0.114 0.04 DBMET01701 | ||
| 0.197 | 0.033 | 0.197 | Anesthetic local | 0.111 0.074 DBMET00318 0.147 0.05 DBMET01700 0.147 0.05 DBMET01701 | ||
| 0.184 | 0.023 | 0.184 | Alpha 1 adrenoreceptor antagonist | 0.081 0.052 DBMET00318 0.145 0.03 DBMET01700 0.145 0.03 DBMET01701 | ||
| 0.179 | 0.018 | 0.287 | NMDA receptor antagonist | 0.281 0.007 DBMET00318 0.287 0.007 DBMET01700 0.287 0.007 DBMET01701 | DBMET01701 | |
| 0.189 | 0.029 | 0.189 | Nav1.3 sodium channel blocker | 0.115 0.079 DBMET00318 0.128 0.066 DBMET01700 0.128 0.066 DBMET01701 | ||
| 0.203 | 0.043 | 0.266 | Diuretic | 0.266 0.028 DBMET00318 0.183 0.052 DBMET01700 0.183 0.052 DBMET01701 | DBMET00318 | |
| 0.167 | 0.009 | 0.167 | Acetylcholine M2 receptor antagonist | 0.141 0.013 DBMET00318 0.136 0.013 DBMET01700 0.136 0.013 DBMET01701 | ||
| 0.233 | 0.076 | 0.233 | Potassium channel (Voltage-sensitive) blocker | 0.169 0.121 DBMET00318 | ||
| 0.183 | 0.027 | 0.183 | Nav1.6 sodium channel blocker | 0.173 0.033 DBMET00318 0.149 0.055 DBMET01700 0.149 0.055 DBMET01701 | ||
| 0.251 | 0.099 | 0.251 | Ca(v)3.3 blocker | 0.208 0.175 DBMET00318 | ||
| 0.158 | 0.01 | 0.173 | Acetylcholine M3 receptor antagonist | 0.106 0.017 DBMET00318 0.173 0.009 DBMET01700 0.173 0.009 DBMET01701 | DBMET01701 | |
| 0.168 | 0.022 | 0.288 | GABA C receptor antagonist | 0.288 0.005 DBMET00318 0.15 0.03 DBMET01700 0.15 0.03 DBMET01701 | DBMET00318 | |
| 0.164 | 0.017 | 0.202 | Prolactin inhibitor | 0.174 0.014 DBMET00318 0.202 0.008 DBMET01700 0.202 0.008 DBMET01701 | DBMET01701 | |
| 0.197 | 0.051 | 0.197 | Antipruritic | 0.196 0.052 DBMET00318 0.19 0.056 DBMET01700 0.19 0.056 DBMET01701 | ||
| 0.152 | 0.007 | 0.214 | NMDA 2A receptor antagonist | 0.16 0.006 DBMET00318 0.214 0.004 DBMET01700 0.214 0.004 DBMET01701 | DBMET01701 | |
| 0.156 | 0.013 | 0.156 | Toll-Like receptor 3 antagonist | 0.13 0.023 DBMET01700 0.13 0.023 DBMET01701 | ||
| 0.154 | 0.015 | 0.321 | Estrogen receptor beta antagonist | 0.168 0.013 DBMET00318 0.321 0.005 DBMET01700 0.321 0.005 DBMET01701 | DBMET01701 | |
| 0.161 | 0.023 | 0.193 | Opioid antagonist | 0.186 0.017 DBMET00318 0.193 0.015 DBMET01700 0.193 0.015 DBMET01701 | DBMET01701 | |
| 0.217 | 0.081 | 0.217 | HERG channel blocker | 0.168 0.112 DBMET00318 | ||
| 0.206 | 0.071 | 0.266 | Neurotrophic factor enhancer | 0.202 0.075 DBMET00318 0.266 0.03 DBMET01700 0.266 0.03 DBMET01701 | DBMET01701 | |
| 0.222 | 0.091 | 0.231 | Tumour necrosis factor alpha release inhibitor | 0.168 0.137 DBMET00318 0.231 0.085 DBMET01700 0.231 0.085 DBMET01701 | DBMET01701 | |
| 0.146 | 0.017 | 0.147 | Inducible nitric-oxide synthase inhibitor | 0.147 0.017 DBMET00318 0.102 0.035 DBMET01700 0.102 0.035 DBMET01701 | DBMET00318 | |
| 0.15 | 0.022 | 0.15 | Nitric-oxide synthase inhibitor | 0.148 0.023 DBMET00318 0.099 0.062 DBMET01700 0.099 0.062 DBMET01701 | ||
| 0.297 | 0.174 | 0.395 | Apoptosis agonist | 0.395 0.116 DBMET01700 0.395 0.116 DBMET01701 | DBMET01701 | |
| 0.173 | 0.054 | 0.229 | Interferon gamma antagonist | 0.191 0.044 DBMET00318 0.229 0.033 DBMET01700 0.229 0.033 DBMET01701 | DBMET01701 | |
| 0.144 | 0.027 | 0.144 | Dopamine antagonist | 0.086 0.044 DBMET00318 0.144 0.027 DBMET01700 0.144 0.027 DBMET01701 | ||
| 0.138 | 0.024 | 0.138 | Acetylcholine nicotinic antagonist | 0.116 0.032 DBMET00318 0.104 0.037 DBMET01700 0.104 0.037 DBMET01701 | ||
| 0.158 | 0.045 | 0.183 | DNA polymerase I inhibitor | 0.175 0.037 DBMET00318 0.183 0.034 DBMET01700 0.183 0.034 DBMET01701 | DBMET01701 | |
| 0.135 | 0.025 | 0.135 | Dopamine D2 antagonist | 0.091 0.035 DBMET00318 0.134 0.025 DBMET01700 0.134 0.025 DBMET01701 | ||
| 0.116 | 0.007 | 0.116 | Histamine agonist | 0.095 0.01 DBMET00318 0.054 0.035 DBMET01700 0.054 0.035 DBMET01701 | ||
| 0.127 | 0.019 | 0.127 | Dopamine D3 antagonist | 0.064 0.042 DBMET00318 0.103 0.024 DBMET01700 0.103 0.024 DBMET01701 | ||
| 0.138 | 0.036 | 0.138 | Nav1.5 sodium channel blocker | 0.134 0.039 DBMET00318 0.1 0.085 DBMET01700 0.1 0.085 DBMET01701 | ||
| 0.132 | 0.03 | 0.15 | Anabolic | 0.144 0.021 DBMET00318 0.15 0.018 DBMET01700 0.15 0.018 DBMET01701 | DBMET01701 | |
| 0.213 | 0.113 | 0.266 | Tyrosine 3 hydroxylase inhibitor | 0.266 0.054 DBMET00318 0.25 0.068 DBMET01700 0.25 0.068 DBMET01701 | DBMET00318 | |
| 0.113 | 0.015 | 0.266 | Estrogen agonist | 0.138 0.012 DBMET00318 0.266 0.006 DBMET01700 0.266 0.006 DBMET01701 | DBMET01701 | |
| 0.112 | 0.014 | 0.148 | Estrogen-related receptor beta agonist | 0.1 0.024 DBMET00318 0.148 0.004 DBMET01700 0.148 0.004 DBMET01701 | DBMET01701 | |
| 0.125 | 0.027 | 0.125 | ABCA1 expression enhancer | 0.11 0.039 DBMET00318 0.122 0.029 DBMET01700 0.122 0.029 DBMET01701 | ||
| 0.143 | 0.046 | 0.156 | Vanilloid 1 agonist | 0.137 0.054 DBMET00318 0.156 0.033 DBMET01700 0.156 0.033 DBMET01701 | DBMET01701 | |
| 0.12 | 0.025 | 0.158 | Opioid mu receptor antagonist | 0.158 0.016 DBMET00318 0.157 0.016 DBMET01700 0.157 0.016 DBMET01701 | DBMET00318 | |
| 0.174 | 0.079 | 0.229 | Nitric oxide antagonist | 0.207 0.065 DBMET00318 0.229 0.058 DBMET01700 0.229 0.058 DBMET01701 | DBMET01701 | |
| 0.097 | 0.005 | 0.105 | Glucocorticoid antagonist | 0.105 0.005 DBMET00318 0.084 0.006 DBMET01700 0.084 0.006 DBMET01701 | DBMET00318 | |
| 0.179 | 0.087 | 0.198 | Anesthetic general | 0.198 0.076 DBMET00318 0.189 0.081 DBMET01700 0.189 0.081 DBMET01701 | DBMET00318 | |
| 0.247 | 0.157 | 0.278 | GABA C receptor rho-3 antagonist | 0.278 0.131 DBMET00318 0.247 0.157 DBMET01700 0.247 0.157 DBMET01701 | DBMET00318 | |
| 0.092 | 0.003 | 0.092 | Histamine H1 receptor agonist | 0.079 0.004 DBMET00318 0.056 0.011 DBMET01700 0.056 0.011 DBMET01701 | ||
| 0.231 | 0.143 | 0.26 | Antithrombotic | 0.26 0.119 DBMET00318 0.246 0.129 DBMET01700 0.246 0.129 DBMET01701 | DBMET00318 | |
| 0.113 | 0.025 | 0.141 | Analgesic, opioid | 0.113 0.025 DBMET00318 0.141 0.017 DBMET01700 0.141 0.017 DBMET01701 | DBMET01701 | |
| 0.144 | 0.059 | 0.144 | Sodium channel (voltage-gated) blocker | 0.139 0.063 DBMET00318 | ||
| 0.092 | 0.009 | 0.235 | Kinesin-like protein 1 inhibitor | 0.235 0.004 DBMET00318 0.088 0.009 DBMET01700 0.088 0.009 DBMET01701 | DBMET00318 | |
| 0.092 | 0.009 | 0.235 | Kinesin antagonist | 0.235 0.004 DBMET00318 0.088 0.009 DBMET01700 0.088 0.009 DBMET01701 | DBMET00318 | |
| 0.107 | 0.024 | 0.271 | Estrogen receptor alpha antagonist | 0.104 0.024 DBMET00318 0.271 0.005 DBMET01700 0.271 0.005 DBMET01701 | DBMET01701 | |
| 0.095 | 0.013 | 0.095 | Glycine transporter inhibitor | 0.076 0.018 DBMET00318 0.06 0.024 DBMET01700 0.06 0.024 DBMET01701 | ||
| 0.216 | 0.134 | 0.232 | Insulysin inhibitor | 0.232 0.115 DBMET00318 0.225 0.123 DBMET01700 0.225 0.123 DBMET01701 | DBMET00318 | |
| 0.162 | 0.084 | 0.262 | Phospholipase C inhibitor | 0.262 0.023 DBMET00318 0.187 0.054 DBMET01700 0.187 0.054 DBMET01701 | DBMET00318 | |
| 0.105 | 0.028 | 0.105 | Glycine receptor antagonist | 0.095 0.037 DBMET00318 0.084 0.051 DBMET01700 0.084 0.051 DBMET01701 | ||
| 0.157 | 0.08 | 0.178 | Arachidonic acid antagonist | 0.173 0.061 DBMET00318 0.178 0.056 DBMET01700 0.178 0.056 DBMET01701 | DBMET01701 | |
| 0.167 | 0.092 | 0.197 | Hepatoprotectant | 0.177 0.082 DBMET00318 0.197 0.066 DBMET01700 0.197 0.066 DBMET01701 | DBMET01701 | |
| 0.149 | 0.075 | 0.149 | GABA C receptor rho-2 antagonist | 0.145 0.08 DBMET01700 0.145 0.08 DBMET01701 | ||
| 0.194 | 0.121 | 0.241 | DNA damaging | 0.241 0.086 DBMET00318 0.218 0.101 DBMET01700 0.218 0.101 DBMET01701 | DBMET00318 | |
| 0.116 | 0.044 | 0.116 | Sphingomyelinase inhibitor | 0.089 0.073 DBMET01700 0.089 0.073 DBMET01701 | ||
| 0.106 | 0.035 | 0.112 | Glutamate release inhibitor | 0.112 0.029 DBMET00318 0.093 0.055 DBMET01700 0.093 0.055 DBMET01701 | DBMET00318 | |
| 0.12 | 0.049 | 0.12 | Acetylcholine release stimulant | |||
| 0.238 | 0.168 | 0.238 | Antiobesity | 0.236 0.171 DBMET00318 | ||
| 0.221 | 0.155 | 0.371 | Interleukin 2 agonist | 0.371 0.037 DBMET00318 0.258 0.11 DBMET01700 0.258 0.11 DBMET01701 | DBMET00318 | |
| 0.078 | 0.012 | 0.105 | Mineralocorticoid receptor antagonist | 0.105 0.007 DBMET00318 0.064 0.017 DBMET01700 0.064 0.017 DBMET01701 | DBMET00318 | |
| 0.114 | 0.048 | 0.114 | Gastric antisecretory | |||
| 0.074 | 0.009 | 0.074 | Histamine H2 receptor agonist | 0.058 0.015 DBMET00318 | ||
| 0.081 | 0.015 | 0.117 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.117 0.009 DBMET00318 0.051 0.029 DBMET01700 0.051 0.029 DBMET01701 | DBMET00318 | |
| 0.088 | 0.024 | 0.183 | Aromatase inhibitor | 0.183 0.009 DBMET00318 0.138 0.015 DBMET01700 0.138 0.015 DBMET01701 | DBMET00318 | |
| 0.097 | 0.033 | 0.097 | 5 Hydroxytryptamine 1F antagonist | |||
| 0.07 | 0.007 | 0.082 | Parathyroid hormone antagonist | 0.082 0.004 DBMET00318 0.059 0.012 DBMET01700 0.059 0.012 DBMET01701 | DBMET00318 | |
| 0.151 | 0.087 | 0.208 | Interleukin 6 antagonist | 0.208 0.036 DBMET00318 0.164 0.071 DBMET01700 0.164 0.071 DBMET01701 | DBMET00318 | |
| 0.135 | 0.072 | 0.135 | Calcium channel blocker | |||
| 0.136 | 0.074 | 0.149 | Histone deacetylase SIRT1 inhibitor | 0.149 0.063 DBMET00318 0.134 0.077 DBMET01700 0.134 0.077 DBMET01701 | DBMET00318 | |
| 0.108 | 0.046 | 0.108 | Glutamate (mGluR7) agonist | |||
| 0.217 | 0.157 | 0.218 | Vasodilator, peripheral | 0.218 0.156 DBMET01700 0.218 0.156 DBMET01701 | DBMET01701 | |
| 0.11 | 0.05 | 0.158 | GABA C receptor rho-1 antagonist | 0.158 0.018 DBMET00318 0.095 0.069 DBMET01700 0.095 0.069 DBMET01701 | DBMET00318 | |
| 0.123 | 0.062 | 0.153 | Cholesterol synthesis inhibitor | 0.136 0.053 DBMET00318 0.153 0.043 DBMET01700 0.153 0.043 DBMET01701 | DBMET01701 | |
| 0.088 | 0.03 | 0.088 | Neuronal nicotinic receptor antagonist | 0.077 0.039 DBMET00318 0.068 0.047 DBMET01700 0.068 0.047 DBMET01701 | ||
| 0.065 | 0.009 | 0.065 | Alpha 1d adrenoreceptor agonist | 0.063 0.01 DBMET00318 0.044 0.022 DBMET01700 0.044 0.022 DBMET01701 | ||
| 0.068 | 0.013 | 0.068 | Alpha 1b adrenoreceptor agonist | 0.06 0.02 DBMET01700 0.06 0.02 DBMET01701 | ||
| 0.091 | 0.037 | 0.158 | NMDA 2 receptor antagonist | 0.154 0.016 DBMET00318 0.158 0.015 DBMET01700 0.158 0.015 DBMET01701 | DBMET01701 | |
| 0.063 | 0.009 | 0.063 | Sigma 1 receptor antagonist | 0.044 0.011 DBMET00318 0.036 0.014 DBMET01700 0.036 0.014 DBMET01701 | ||
| 0.091 | 0.039 | 0.093 | Nicotinic alpha4beta2 receptor antagonist | 0.093 0.037 DBMET00318 | DBMET00318 | |
| 0.209 | 0.157 | 0.263 | Cholesterol antagonist | 0.21 0.156 DBMET00318 0.263 0.116 DBMET01700 0.263 0.116 DBMET01701 | DBMET01701 | |
| 0.087 | 0.035 | 0.087 | Epoxide hydrolase inhibitor | |||
| 0.109 | 0.058 | 0.382 | GABA C receptor agonist | 0.382 0.005 DBMET00318 | DBMET00318 | |
| 0.113 | 0.065 | 0.113 | Calcium channel (voltage-sensitive) blocker | |||
| 0.074 | 0.026 | 0.074 | Transcription factor AP-1 inhibitor | 0.067 0.034 DBMET00318 0.068 0.033 DBMET01700 0.068 0.033 DBMET01701 | ||
| 0.08 | 0.034 | 0.08 | Phospholipase D inhibitor | |||
| 0.082 | 0.037 | 0.082 | Calcium channel L-type blocker | |||
| 0.062 | 0.017 | 0.082 | Opioid kappa receptor agonist | 0.082 0.012 DBMET00318 0.075 0.013 DBMET01700 0.075 0.013 DBMET01701 | DBMET00318 | |
| 0.07 | 0.025 | 0.076 | Heme oxygenase stimulant | 0.062 0.041 DBMET00318 0.076 0.019 DBMET01700 0.076 0.019 DBMET01701 | DBMET01701 | |
| 0.095 | 0.05 | 0.122 | Androgen antagonist | 0.084 0.061 DBMET00318 0.122 0.032 DBMET01700 0.122 0.032 DBMET01701 | DBMET01701 | |
| 0.065 | 0.021 | 0.065 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.061 | 0.017 | 0.061 | Adenylate cyclase 1 inhibitor | 0.06 0.018 DBMET00318 0.048 0.028 DBMET01700 0.048 0.028 DBMET01701 | ||
| 0.094 | 0.051 | 0.122 | Ornithine decarboxylase inhibitor | 0.122 0.025 DBMET00318 0.096 0.049 DBMET01700 0.096 0.049 DBMET01701 | DBMET00318 | |
| 0.075 | 0.032 | 0.093 | 5 Hydroxytryptamine 2A agonist | 0.093 0.018 DBMET00318 0.072 0.034 DBMET01700 0.072 0.034 DBMET01701 | DBMET00318 | |
| 0.057 | 0.013 | 0.057 | Glycine transporter 1 inhibitor | 0.052 0.015 DBMET00318 | ||
| 0.058 | 0.015 | 0.136 | Estrogen receptor alpha agonist | 0.069 0.014 DBMET00318 0.136 0.005 DBMET01700 0.136 0.005 DBMET01701 | DBMET01701 | |
| 0.16 | 0.117 | 0.179 | Anticonvulsant | 0.179 0.1 DBMET00318 | DBMET00318 | |
| 0.068 | 0.026 | 0.074 | Prolactin release inhibitor | 0.074 0.017 DBMET00318 0.068 0.027 DBMET01700 0.068 0.027 DBMET01701 | DBMET00318 | |
| 0.073 | 0.031 | 0.174 | NMDA 2C receptor antagonist | 0.174 0.005 DBMET00318 0.09 0.019 DBMET01700 0.09 0.019 DBMET01701 | DBMET00318 | |
| 0.043 | 0.003 | 0.055 | NMDA receptor phencyclidine site antagonist | 0.034 0.004 DBMET00318 0.055 0.003 DBMET01700 0.055 0.003 DBMET01701 | DBMET01701 | |
| 0.063 | 0.023 | 0.063 | 5 Hydroxytryptamine 1B agonist | 0.051 0.04 DBMET01700 0.051 0.04 DBMET01701 | ||
| 0.077 | 0.038 | 0.13 | Opioid delta receptor antagonist | 0.116 0.027 DBMET00318 0.13 0.023 DBMET01700 0.13 0.023 DBMET01701 | DBMET01701 | |
| 0.113 | 0.075 | 0.129 | Alkylator | 0.11 0.077 DBMET00318 0.129 0.06 DBMET01700 0.129 0.06 DBMET01701 | DBMET01701 | |
| 0.112 | 0.074 | 0.159 | Adenylate cyclase inhibitor | 0.159 0.039 DBMET00318 0.136 0.055 DBMET01700 0.136 0.055 DBMET01701 | DBMET00318 | |
| 0.173 | 0.137 | 0.27 | Immunostimulant | 0.27 0.088 DBMET00318 0.195 0.123 DBMET01700 0.195 0.123 DBMET01701 | DBMET00318 | |
| 0.045 | 0.011 | 0.045 | Melatonin agonist | 0.039 0.016 DBMET01700 0.039 0.016 DBMET01701 | ||
| 0.075 | 0.041 | 0.075 | Alpha adrenoreceptor agonist | 0.068 0.047 DBMET01700 0.068 0.047 DBMET01701 | ||
| 0.176 | 0.143 | 0.253 | Interleukin agonist | 0.253 0.077 DBMET00318 | DBMET00318 | |
| 0.069 | 0.036 | 0.096 | Beta 3 adrenoreceptor antagonist | 0.096 0.016 DBMET01700 0.096 0.016 DBMET01701 | DBMET01701 | |
| 0.087 | 0.054 | 0.101 | Myeloperoxidase inhibitor | 0.101 0.034 DBMET00318 0.095 0.041 DBMET01700 0.095 0.041 DBMET01701 | DBMET00318 | |
| 0.049 | 0.016 | 0.086 | GABA uptake inhibitor | 0.086 0.004 DBMET00318 0.038 0.03 DBMET01700 0.038 0.03 DBMET01701 | DBMET00318 | |
| 0.051 | 0.019 | 0.163 | Estrogen receptor beta agonist | 0.096 0.012 DBMET00318 0.163 0.006 DBMET01700 0.163 0.006 DBMET01701 | DBMET01701 | |
| 0.043 | 0.011 | 0.043 | Melatonin receptor 1A agonist | 0.033 0.023 DBMET01700 0.033 0.023 DBMET01701 | ||
| 0.066 | 0.035 | 0.066 | Bombesin 1 receptor agonist | 0.059 0.042 DBMET01700 0.059 0.042 DBMET01701 | ||
| 0.051 | 0.021 | 0.065 | Geranyltranstransferase inhibitor | 0.065 0.01 DBMET00318 | DBMET00318 | |
| 0.088 | 0.058 | 0.113 | Histamine N-methyltransferase inhibitor | 0.113 0.035 DBMET00318 0.077 0.071 DBMET01700 0.077 0.071 DBMET01701 | DBMET00318 | |
| 0.061 | 0.035 | 0.061 | Alpha 1 adrenoreceptor agonist | 0.053 0.046 DBMET01700 0.053 0.046 DBMET01701 | ||
| 0.039 | 0.013 | 0.039 | Sigma 2 receptor antagonist | 0.032 0.015 DBMET00318 0.038 0.013 DBMET01700 0.038 0.013 DBMET01701 | ||
| 0.041 | 0.014 | 0.041 | Melatonin 1 agonist | 0.036 0.019 DBMET01700 0.036 0.019 DBMET01701 | ||
| 0.046 | 0.021 | 0.102 | Dopamine D5 agonist | 0.102 0.004 DBMET00318 0.089 0.005 DBMET01700 0.089 0.005 DBMET01701 | DBMET00318 | |
| 0.115 | 0.09 | 0.115 | Sodium channel blocker | 0.107 0.102 DBMET00318 | ||
| 0.081 | 0.056 | 0.131 | Adrenaline agonist | 0.131 0.021 DBMET01700 0.131 0.021 DBMET01701 | DBMET01701 | |
| 0.055 | 0.032 | 0.055 | 5 Hydroxytryptamine 2 agonist | 0.054 0.033 DBMET00318 | ||
| 0.06 | 0.037 | 0.06 | Calcium channel T-type blocker | 0.055 0.045 DBMET00318 | ||
| 0.054 | 0.032 | 0.054 | Alpha 1L adrenoreceptor antagonist | 0.053 0.035 DBMET00318 0.053 0.035 DBMET01700 0.053 0.035 DBMET01701 | ||
| 0.076 | 0.054 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 DBMET00318 0.079 0.051 DBMET01700 0.079 0.051 DBMET01701 | DBMET00318 | |
| 0.058 | 0.038 | 0.058 | 5 Hydroxytryptamine 6 antagonist | |||
| 0.142 | 0.122 | 0.169 | Neurotensin receptor agonist | 0.169 0.063 DBMET00318 0.167 0.067 DBMET01700 0.167 0.067 DBMET01701 | DBMET00318 | |
| 0.032 | 0.013 | 0.032 | Epoxide hydrolase 2 inhibitor | |||
| 0.074 | 0.054 | 0.074 | Vanilloid 4 agonist | |||
| 0.037 | 0.018 | 0.038 | Melatonin 2 agonist | 0.038 0.017 DBMET01700 0.038 0.017 DBMET01701 | DBMET01701 | |
| 0.05 | 0.031 | 0.053 | Histamine H4 receptor antagonist | 0.053 0.027 DBMET00318 | DBMET00318 | |
| 0.042 | 0.024 | 0.083 | NMDA receptor subunit 3A antagonist | 0.044 0.023 DBMET00318 0.083 0.011 DBMET01700 0.083 0.011 DBMET01701 | DBMET01701 | |
| 0.117 | 0.1 | 0.117 | Neurotrophic factor | 0.115 0.104 DBMET00318 0.116 0.101 DBMET01700 0.116 0.101 DBMET01701 | ||
| 0.045 | 0.029 | 0.091 | NMDA receptor subunit 3B antagonist | 0.049 0.026 DBMET00318 0.091 0.012 DBMET01700 0.091 0.012 DBMET01701 | DBMET01701 | |
| 0.053 | 0.038 | 0.053 | Nicotinic receptor alpha7 subunit antagonist | |||
| 0.044 | 0.03 | 0.057 | Dopamine D5 antagonist | 0.045 0.029 DBMET00318 0.057 0.021 DBMET01700 0.057 0.021 DBMET01701 | DBMET01701 | |
| 0.023 | 0.009 | 0.023 | Histamine H4 receptor agonist | 0.02 0.011 DBMET00318 | ||
| 0.03 | 0.017 | 0.03 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.032 | 0.02 | 0.032 | Endothelial nitric-oxide synthase inhibitor | 0.029 0.024 DBMET00318 | ||
| 0.025 | 0.013 | 0.025 | Alpha 1a adrenoreceptor agonist | |||
| 0.042 | 0.031 | 0.042 | Alpha 1L adrenoreceptor agonist | |||
| 0.026 | 0.016 | 0.026 | Vanilloid 2 agonist | |||
| 0.049 | 0.041 | 0.07 | Opioid agonist | 0.07 0.023 DBMET00318 0.067 0.025 DBMET01700 0.067 0.025 DBMET01701 | DBMET00318 | |
| 0.034 | 0.026 | 0.061 | Retinoid X receptor agonist | 0.061 0.014 DBMET00318 | DBMET00318 | |
| 0.027 | 0.02 | 0.028 | Hedgehog signaling activator | 0.028 0.018 DBMET00318 | DBMET00318 | |
| 0.022 | 0.015 | 0.028 | Estrone sulfatase inhibitor | 0.028 0.011 DBMET00318 0.028 0.011 DBMET01700 0.028 0.011 DBMET01701 | DBMET01701 | |
| 0.111 | 0.103 | 0.157 | Protein kinase stimulant | 0.157 0.064 DBMET00318 0.152 0.067 DBMET01700 0.152 0.067 DBMET01701 | DBMET00318 | |
| 0.033 | 0.026 | 0.034 | Progesterone antagonist | 0.034 0.025 DBMET01700 0.034 0.025 DBMET01701 | DBMET01701 | |
| 0.047 | 0.041 | 0.066 | Beta 2 adrenoreceptor antagonist | 0.066 0.019 DBMET01700 0.066 0.019 DBMET01701 | DBMET01701 | |
| 0.027 | 0.022 | 0.027 | Melatonin antagonist | |||
| 0.051 | 0.046 | 0.069 | Beta 1 adrenoreceptor antagonist | 0.069 0.027 DBMET01700 0.069 0.027 DBMET01701 | DBMET01701 | |
| 0.026 | 0.022 | 0.026 | 5 Hydroxytryptamine 1D agonist | |||
| 0.031 | 0.029 | 0.048 | Retinoid X alpha receptor agonist | 0.048 0.015 DBMET00318 | DBMET00318 | |
| 0.026 | 0.023 | 0.03 | Thrombin receptor antagonist | 0.03 0.018 DBMET00318 | DBMET00318 | |
| 0.024 | 0.022 | 0.024 | Acid ceramidase inhibitor | |||
| 0.013 | 0.011 | 0.013 | Melatonin receptor 1A antagonist | |||
| 0.021 | 0.02 | 0.028 | Dopamine D1 agonist | 0.022 0.018 DBMET00318 0.028 0.01 DBMET01700 0.028 0.01 DBMET01701 | DBMET01701 | |
| 0.053 | 0.052 | 0.068 | Androgen agonist | 0.053 0.051 DBMET00318 0.068 0.032 DBMET01700 0.068 0.032 DBMET01701 | DBMET01701 | |
| 0.108 | 0.107 | 0.108 | Toll-Like receptor antagonist | |||
| 0.039 | 0.039 | 0.041 | Liver X receptor agonist | 0.041 0.034 DBMET01700 0.041 0.034 DBMET01701 | DBMET01701 | |
| 0.03 | 0.031 | 0.041 | Carboxypeptidase B inhibitor | 0.041 0.012 DBMET00318 | DBMET00318 | |
| 0.024 | 0.026 | 0.029 | RNA-directed RNA polymerase stimulant | 0.029 0.022 DBMET00318 0.025 0.024 DBMET01700 0.025 0.024 DBMET01701 | DBMET00318 | |
| 0.057 | 0.06 | 0.077 | Beta adrenoreceptor antagonist | 0.077 0.029 DBMET01700 0.077 0.029 DBMET01701 | DBMET01701 | |
| 0.064 | 0.068 | 0.094 | CYP2A6 inhibitor | 0.094 0.039 DBMET00318 | DBMET00318 | |
| 0.016 | 0.02 | 0.022 | Estrogen-related receptor gamma agonist | 0.022 0.008 DBMET01700 0.022 0.008 DBMET01701 | DBMET01701 | |
| 0.013 | 0.018 | 0.017 | Progesterone agonist | 0.017 0.013 DBMET00318 | DBMET00318 | |
| 0.012 | 0.019 | 0.019 | Ileal bile acid transport inhibitor | 0.019 0.01 DBMET01700 0.019 0.01 DBMET01701 | DBMET01701 | |
| 0.019 | 0.027 | 0.022 | Vitamin D receptor antagonist | 0.022 0.015 DBMET00318 | DBMET00318 | |
| 0.027 | 0.035 | 0.05 | Arginase inhibitor | 0.05 0.015 DBMET00318 | DBMET00318 | |
| 0.161 | 0.169 | 0.341 | Superoxide dismutase inhibitor | 0.341 0.038 DBMET00318 0.2 0.117 DBMET01700 0.2 0.117 DBMET01701 | DBMET00318 | |
| 0.038 | 0.047 | 0.05 | Melanocortin antagonist | 0.05 0.03 DBMET00318 | DBMET00318 | |
| 0.086 | 0.095 | 0.138 | 5 Hydroxytryptamine 3A agonist | 0.138 0.042 DBMET00318 | DBMET00318 | |
| 0.09 | 0.101 | 0.1 | Histone deacetylase class III inhibitor | 0.1 0.09 DBMET00318 | DBMET00318 | |
| 0.059 | 0.071 | 0.076 | Aminopeptidase I inhibitor | 0.076 0.047 DBMET00318 | DBMET00318 | |
| 0.031 | 0.045 | 0.04 | Oxytocin agonist | 0.04 0.032 DBMET00318 0.038 0.034 DBMET01700 0.038 0.034 DBMET01701 | DBMET00318 | |
| 0.023 | 0.038 | 0.028 | Purinergic P2Y15 antagonist | 0.028 0.021 DBMET00318 | DBMET00318 | |
| 0.017 | 0.036 | 0.028 | Melanocortin 5 antagonist | 0.028 0.017 DBMET00318 | DBMET00318 | |
| 0.05 | 0.069 | 0.059 | Lipocortins synthesis agonist | 0.059 0.038 DBMET00318 0.058 0.041 DBMET01700 0.058 0.041 DBMET01701 | DBMET00318 | |
| 0.074 | 0.093 | 0.11 | Bronchodilator | 0.11 0.052 DBMET01700 0.11 0.052 DBMET01701 | DBMET01701 | |
| 0.02 | 0.039 | 0.027 | Calcium-sensing receptor agonist | 0.027 0.018 DBMET00318 | DBMET00318 | |
| 0.095 | 0.115 | 0.106 | Acetylcholinesterase inhibitor | 0.106 0.095 DBMET01700 0.106 0.095 DBMET01701 | DBMET01701 | |
| 0.049 | 0.071 | 0.059 | NMDA receptor agonist | 0.059 0.048 DBMET00318 | DBMET00318 | |
| 0.045 | 0.068 | 0.07 | Botulinum neurotoxin type A inhibitor | 0.07 0.025 DBMET00318 | DBMET00318 | |
| 0.033 | 0.056 | 0.052 | Opioid mu receptor agonist | 0.052 0.028 DBMET00318 0.05 0.029 DBMET01700 0.05 0.029 DBMET01701 | DBMET00318 | |
| 0.045 | 0.069 | 0.069 | Dopamine agonist | 0.069 0.045 DBMET01700 0.069 0.045 DBMET01701 | DBMET01701 | |
| 0.076 | 0.1 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.115 0.035 DBMET00318 | DBMET00318 | |
| 0.125 | 0.149 | 0.136 | Ca2+-transporting ATPase inhibitor | 0.136 0.092 DBMET00318 | DBMET00318 | |
| 0.03 | 0.054 | 0.047 | AMPA 4 receptor antagonist | 0.047 0.018 DBMET00318 | DBMET00318 | |
| 0.043 | 0.067 | 0.05 | Vanilloid 2 antagonist | 0.05 0.043 DBMET01700 0.05 0.043 DBMET01701 | DBMET01701 | |
| 0.083 | 0.109 | 0.154 | Nav1.4 sodium channel blocker | 0.154 0.032 DBMET00318 0.096 0.082 DBMET01700 0.096 0.082 DBMET01701 | DBMET00318 | |
| 0.039 | 0.065 | 0.052 | Dopamine beta hydroxylase inhibitor | 0.052 0.026 DBMET00318 | DBMET00318 | |
| 0.023 | 0.052 | 0.042 | Dipeptidyl peptidase II inhibitor | 0.042 0.013 DBMET00318 | DBMET00318 | |
| 0.019 | 0.049 | 0.027 | Liver X receptor alpha antagonist | 0.027 0.025 DBMET01700 0.027 0.025 DBMET01701 | DBMET01701 | |
| 0.047 | 0.078 | 0.067 | Lipase inhibitor | 0.067 0.057 DBMET01700 0.067 0.057 DBMET01701 | DBMET01701 | |
| 0.053 | 0.086 | 0.072 | Glutamate (mGluR7) antagonist | 0.072 0.039 DBMET00318 | DBMET00318 | |
| 0.039 | 0.074 | 0.054 | Lysine-specific demethylase 1A inhibitor | 0.054 0.038 DBMET00318 | DBMET00318 | |
| 0.048 | 0.089 | 0.071 | Sirtuin 1 inhibitor | 0.071 0.043 DBMET00318 | DBMET00318 | |
| 0.029 | 0.07 | 0.045 | Nicotinic receptor alpha3 subunit antagonist | 0.045 0.029 DBMET00318 | DBMET00318 | |
| 0.028 | 0.07 | 0.042 | 5 Hydroxytryptamine 2B agonist | 0.042 0.021 DBMET00318 | DBMET00318 | |
| 0.052 | 0.094 | 0.063 | Beta 2 adrenoreceptor agonist | 0.063 0.039 DBMET01700 0.063 0.039 DBMET01701 | DBMET01701 | |
| 0.055 | 0.098 | 0.145 | Glycine receptor agonist | 0.145 0.007 DBMET00318 | DBMET00318 | |
| 0.084 | 0.127 | 0.106 | Photosensitizer | 0.106 0.077 DBMET00318 | DBMET00318 | |
| 0.033 | 0.076 | 0.043 | Aldosterone antagonist | 0.043 0.041 DBMET00318 | DBMET00318 | |
| 0.009 | 0.057 | 0.026 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.026 0.014 DBMET01700 0.026 0.014 DBMET01701 | DBMET01701 | |
| 0.061 | 0.109 | 0.139 | Aminopeptidase B inhibitor | 0.139 0.043 DBMET00318 | DBMET00318 | |
| 0.034 | 0.087 | 0.065 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.049 0.045 DBMET00318 0.065 0.025 DBMET01700 0.065 0.025 DBMET01701 | DBMET01701 | |
| 0.017 | 0.07 | 0.028 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.028 0.027 DBMET01700 0.028 0.027 DBMET01701 | DBMET01701 | |
| 0.07 | 0.126 | 0.091 | Bile acid receptor antagonist | 0.091 0.071 DBMET01700 0.091 0.071 DBMET01701 | DBMET01701 | |
| 0.035 | 0.09 | 0.089 | CXC chemokine 4 receptor antagonist | 0.089 0.028 DBMET00318 | DBMET00318 | |
| 0.019 | 0.075 | 0.061 | Estradiol 17 beta-dehydrogenase inhibitor | 0.061 0.019 DBMET01700 0.061 0.019 DBMET01701 | DBMET01701 | |
| 0.038 | 0.094 | 0.054 | Dipeptidyl peptidase inhibitor | 0.054 0.034 DBMET00318 | DBMET00318 | |
| 0.047 | 0.107 | 0.061 | Potassium channel large-conductance Ca-activated activator | 0.061 0.058 DBMET01700 0.061 0.058 DBMET01701 | DBMET01701 | |
| 0.083 | 0.147 | 0.104 | Cathepsin H inhibitor | 0.104 0.1 DBMET00318 | DBMET00318 | |
| 0.079 | 0.146 | 0.108 | Aldehyde dehydrogenase inhibitor | 0.102 0.095 DBMET00318 0.108 0.086 DBMET01700 0.108 0.086 DBMET01701 | DBMET01701 | |
| 0.15 | 0.219 | 0.229 | Hypoxia-inducible factor 1 alpha inhibitor | 0.229 0.12 DBMET01700 0.229 0.12 DBMET01701 | DBMET01701 | |
| 0.074 | 0.145 | 0.122 | Bone formation stimulant | 0.122 0.084 DBMET00318 0.121 0.085 DBMET01700 0.121 0.085 DBMET01701 | DBMET00318 | |
| 0.028 | 0.099 | 0.039 | Kainate receptor agonist | 0.039 0.033 DBMET00318 | DBMET00318 | |
| 0.008 | 0.082 | 0.049 | Somatostatin 2 antagonist | 0.049 0.015 DBMET00318 | DBMET00318 | |
| 0.046 | 0.126 | 0.075 | Glutamate dehydrogenase inhibitor | 0.075 0.05 DBMET00318 | DBMET00318 | |
| 0.053 | 0.135 | 0.075 | Antineoplastic alkaloid | 0.075 0.072 DBMET01700 0.075 0.072 DBMET01701 | DBMET01701 | |
| 0.075 | 0.161 | 0.17 | Lipid peroxidase inhibitor | 0.17 0.056 DBMET01700 0.17 0.056 DBMET01701 | DBMET01701 | |
| 0.032 | 0.119 | 0.051 | Sphingosine kinase 2 inhibitor | 0.051 0.046 DBMET00318 | DBMET00318 | |
| 0.05 | 0.136 | 0.078 | Keratolytic | 0.078 0.051 DBMET00318 | DBMET00318 | |
| 0.055 | 0.142 | 0.094 | GABA B receptor agonist | 0.094 0.021 DBMET00318 | DBMET00318 | |
| 0.02 | 0.107 | 0.053 | Beta tubulin antagonist | 0.053 0.045 DBMET01700 0.053 0.045 DBMET01701 | DBMET01701 | |
| 0.015 | 0.104 | 0.061 | Somatostatin 1 antagonist | 0.061 0.014 DBMET00318 | DBMET00318 | |
| 0.094 | 0.182 | 0.294 | Growth hormone agonist | 0.294 0.034 DBMET00318 | DBMET00318 | |
| 0.01 | 0.1 | 0.023 | Somatostatin 4 antagonist | 0.023 0.017 DBMET00318 | DBMET00318 | |
| 0.094 | 0.187 | 0.12 | Papain-like protease (SARS coronavirus) inhibitor | 0.12 0.081 DBMET01700 0.12 0.081 DBMET01701 | DBMET01701 | |
| 0.155 | 0.249 | 0.201 | Immunosuppressant | 0.201 0.197 DBMET01700 0.201 0.197 DBMET01701 | DBMET01701 | |
| 0.046 | 0.143 | 0.072 | Glutamate (mGluR6) antagonist | 0.072 0.036 DBMET00318 | DBMET00318 | |
| 0.027 | 0.126 | 0.047 | Aconitate hydratase inhibitor | 0.047 0.045 DBMET00318 | DBMET00318 | |
| 0.043 | 0.142 | 0.125 | Somatostatin 1 agonist | 0.125 0.021 DBMET00318 | DBMET00318 | |
| 0.042 | 0.149 | 0.093 | GABA aminotransferase inhibitor | 0.093 0.033 DBMET00318 | DBMET00318 | |
| 0.116 | 0.224 | 0.132 | Heat shock protein 70 antagonist | 0.132 0.11 DBMET00318 | DBMET00318 | |
| 0.154 | 0.264 | 0.238 | Caspase 3 stimulant | 0.238 0.124 DBMET01700 0.238 0.124 DBMET01701 | DBMET01701 | |
| 0.107 | 0.218 | 0.141 | Succinate dehydrogenase inhibitor | 0.141 0.129 DBMET00318 | DBMET00318 | |
| 0.017 | 0.128 | 0.047 | Ornithine carbamoyltransferase inhibitor | 0.047 0.043 DBMET00318 | DBMET00318 | |
| 0.067 | 0.181 | 0.107 | DOPA decarboxylase inhibitor | 0.107 0.063 DBMET00318 0.102 0.072 DBMET01700 0.102 0.072 DBMET01701 | DBMET00318 | |
| 0.153 | 0.267 | 0.274 | 15-Lipoxygenase inhibitor | 0.274 0.147 DBMET01700 0.274 0.147 DBMET01701 | DBMET01701 | |
| 0.015 | 0.132 | 0.033 | Tryptase inhibitor | 0.033 0.032 DBMET00318 | DBMET00318 | |
| 0.021 | 0.138 | 0.038 | Neurokinin 2 agonist | 0.038 0.034 DBMET00318 | DBMET00318 | |
| 0.052 | 0.172 | 0.1 | Ferrochelatase inhibitor | 0.1 0.071 DBMET00318 | DBMET00318 | |
| 0.015 | 0.146 | 0.038 | Glutamate (mGluR3) antagonist | 0.038 0.023 DBMET00318 | DBMET00318 | |
| 0.089 | 0.223 | 0.132 | Melanin inhibitor | 0.132 0.11 DBMET01700 0.132 0.11 DBMET01701 | DBMET01701 | |
| 0.063 | 0.203 | 0.104 | Cyclooxygenase 3 inhibitor | 0.104 0.097 DBMET00318 | DBMET00318 | |
| 0.066 | 0.218 | 0.198 | Angiogenesis stimulant | 0.198 0.096 DBMET00318 0.135 0.132 DBMET01700 0.135 0.132 DBMET01701 | DBMET00318 | |
| 0.036 | 0.192 | 0.093 | Topoisomerase I inhibitor | 0.093 0.076 DBMET01700 0.093 0.076 DBMET01701 | DBMET01701 | |
| 0.03 | 0.187 | 0.069 | Topoisomerase II alpha inhibitor | 0.069 0.063 DBMET01700 0.069 0.063 DBMET01701 | DBMET01701 | |
| 0.072 | 0.229 | 0.121 | Phospholipase A2 inhibitor | 0.121 0.116 DBMET00318 | DBMET00318 | |
| 0.009 | 0.173 | 0.035 | Vascular adhesion protein 1 inhibitor | 0.035 0.033 DBMET00318 | DBMET00318 | |
| 0.138 | 0.303 | 0.201 | Apoptosis antagonist | 0.201 0.178 DBMET01700 0.201 0.178 DBMET01701 | DBMET01701 | |
| 0.07 | 0.243 | 0.113 | Transcription factor STAT6 inhibitor | 0.113 0.074 DBMET00318 | DBMET00318 | |
| 0.041 | 0.217 | 0.084 | HIV-1 integrase (Overall Integration) inhibitor | 0.084 0.073 DBMET00318 | DBMET00318 | |
| 0.015 | 0.192 | 0.036 | Estrogen-related receptor beta antagonist | 0.036 0.016 DBMET01700 0.036 0.016 DBMET01701 | DBMET01701 | |
| 0.021 | 0.204 | 0.041 | GABA B receptor antagonist | 0.041 0.032 DBMET00318 | DBMET00318 | |
| 0.052 | 0.242 | 0.088 | Carbonic anhydrase XV inhibitor | 0.088 0.086 DBMET00318 | DBMET00318 | |
| 0.024 | 0.219 | 0.08 | Glutamate decarboxylase inhibitor | 0.08 0.044 DBMET00318 | DBMET00318 | |
| 0.01 | 0.21 | 0.029 | Somatostatin agonist | 0.029 0.024 DBMET00318 | DBMET00318 | |
| 0.013 | 0.218 | 0.051 | Somatostatin 5 agonist | 0.051 0.012 DBMET00318 | DBMET00318 | |
| 0.021 | 0.226 | 0.067 | Porphobilinogen synthase inhibitor | 0.067 0.059 DBMET00318 | DBMET00318 | |
| 0.013 | 0.224 | 0.041 | Growth hormone release inhibitor | 0.041 0.03 DBMET00318 | DBMET00318 | |
| 0.053 | 0.266 | 0.158 | Amyloid beta aggregation inhibitor | 0.158 0.102 DBMET01700 0.158 0.102 DBMET01701 | DBMET01701 | |
| 0.082 | 0.296 | 0.229 | Antioxidant | 0.229 0.096 DBMET01700 0.229 0.096 DBMET01701 | DBMET01701 | |
| 0.062 | 0.28 | 0.12 | Farnesoid X receptor antagonist | 0.12 0.103 DBMET01700 0.12 0.103 DBMET01701 | DBMET01701 | |
| 0.027 | 0.248 | 0.113 | M18 aspartyl aminopeptidase inhibitor | 0.113 0.077 DBMET01700 0.113 0.077 DBMET01701 | DBMET01701 | |
| 0.005 | 0.225 | 0.042 | Somatostatin 5 antagonist | 0.042 0.017 DBMET00318 | DBMET00318 | |
| 0.035 | 0.257 | 0.1 | Glutamate receptor antagonist | 0.1 0.097 DBMET00318 | DBMET00318 | |
| 0.152 | 0.402 | 0.245 | 5 Hydroxytryptamine release inhibitor | 0.245 0.235 DBMET00318 | DBMET00318 | |
| 0.085 | 0.41 | 0.201 | Immunomodulator | 0.201 0.163 DBMET00318 | DBMET00318 | |
| 0.044 | 0.373 | 0.196 | Interleukin antagonist | 0.196 0.086 DBMET00318 | DBMET00318 | |
| 0.037 | 0.45 | 0.18 | Free radical scavenger | 0.18 0.115 DBMET01700 0.18 0.115 DBMET01701 | DBMET01701 | |
| 0.045 | 0.664 | 0.151 | Death-associated protein kinase 2 inhibitor | 0.151 0.105 DBMET00318 | DBMET00318 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |